-+ 0.00%
-+ 0.00%
-+ 0.00%

Bausch + Lomb reports 24-month U.S. ELIOS glaucoma trial results with 76% achieving ≥20% IOP reduction

Reuters·03/23/2026 11:01:42

Please log in to view news